Aerovate Therapeutics Inc
Aerovate Therapeutics Inc Stock, NASDAQ:AVTE
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focus on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake in July 27, 2018 and is headquartered in Boston, MA.